JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (11): 1037-1040.doi: 10.3969/j.issn.1005-6483.2022.11.011

Previous Articles     Next Articles

LINC00221 promotes proliferation,migration and invasion in hepatocellular carcinoma through ERK signaling pathway

  

  1. Department of Radiotherapy 2,Qingdao Central Hospital Affiliated to Qingdao University,Shandong,Qingdao 266042, China
  • Received:2022-07-11 Accepted:2022-07-11 Online:2022-11-20 Published:2022-11-20

Abstract: Objective To investigate the biological role and the potential mechanisms of LINC00221 in proliferation,migration and invasion of hepatocellular carcinoma(HCC) through ERK signaling pathway. Methods qRT-PCR was used to detect the expression of LINC00221 in HCC cell lines.MHCC-LM3 cell were divided into Blank control group,Negative control group,siRNA-LINC00221 group and siRNA-LINC00221+ERK activator group.The cell proliferation,migration and invasion capabilities were detected by Cell Counting Kit-8(CCK-8),wound-healing assay and Transwell assay.The expressions of MEK1/2 and p-ERK1/2 were examined by Western blot. Results LINC00221 expression were highly expressed in HCC cell lines(P<0.05).Compared with negative control group,the proliferation,migration and invasion abilities of siRNA-LINC00221 group were inhibited(P<0.01).Rescue experiments showed that the proliferation,migration and invasion of siRNA-LINC00221+ERK activator group were promoted as compared with siRNA-LINC00221 group(P<0.01).Compared with Negative control group,the expressions of MEK1/2 and p-ERK1/2 were decreased in siRNA-LINC00221 group(P<0.01).While MEK1/2 and p-ERK1/2 expression of siRNA-LINC00221+ERK activator group were increased as compared with siRNA-LINC00221 group(P<0.01). Conclusion LINC00221 promotes HCC development via increasing activity of ERK/MEK pathway.LINC00221 may serve as a promising,novel therapeutic target in HCC.

Key words: hepatocellular carcinoma, LINC00221, invasion, migration, ERK signaling pathway

[1] LIU Kai, LI Bo, WU Xiangtian, et al. Mechanism study of metformin inhibiting migration and invasion of non-small cell lung cancer A549 cell through LncRNA-H19 [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 719-721.
[2] LI Xin, GAI Huirong, SONG Lei, et al. SRGAP3-AS2 regulates non-small cell lung cancer cell proliferation,migration and invasion via JAK signaling pathway [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 727-730.
[3] YIN Junfeng, GU Ming. The effect of circ_0007385 silence on the proliferation,migration and apoptosis of colon cancer cells [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(8): 762-766.
[4] RUAN Tian, LI Changsheng, YANG Zetian, et al. The effect of visceral pleural invasion on the survival of postoperative patients with stage ⅢA/N2 non-small cell lung cancer:SEER database analysis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 448-452.
[5] YANG Gang, WANG Guan, XIONG Yongfu, et al. Study on the expression of TP53 regulation of apoptosis inhibitor 1 in hepatoma cells and its effect on proliferation and apoptosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 471-474.
[6] LIN Meilong, WANG Wenqiang, LI Jian, et al. The diagnostic value of folate receptor-positive circulating tumor cells detection in patients with hepatocellular carcinoma with vascular invasion [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 364-367.
[7] ZHU Dongliang, LI Weihao, YAN Haidong, et al. Apatinib reduces the invasion ability of colon cancer cells and its molecular mechanism [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 179-181.
[8] YANG Jun, SUN Long, ZHAO Jianquan, et al. Relationship of plant homeodomain finger protein 2 expression with clinicopathological features and prognosis in hepatocellular carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(11): 1041-1043.
[9] ZHU Min, DENG Kexue, QIU Jun, et al. Evaluation of glioma grade by IVIM and its correlation with Ki-67 index [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(10): 925-929.
[10] NI zhifu, WANG Xiaoling, QU Zhenfan, et al.. The molecular mechanism of lncRNA SNHG16 regulating the proliferation,migration,invasion and apoptosis of Wilms’ tumor WIT49 cells by targeting miR-22-3p [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 883-888.
[11] . Clinical application of autologous tumor infiltrating lymphocytes combined with antiPD1 antibody in the treatment of advanced hepatocellular carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(8): 743-747.
[12] . Effect on liver hyperplasia and hepatocellular carcinoma growth after liver arterial ligation combined with partial portal ligation [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(4): 367-371.
[13] ZHOU Bei, WANG Jing, LI Zhongyang.. miR-597 inhibits breast cancer cell proliferation,migration and invasion through FOSL2 [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(3): 248-252.
[14] . Expression of stanniocalcin2 in AFP positive gastric cancer and its prognostic value [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(2): 148-150.
[15] WANG Haijuan, ZHENG Yabin, ZHANG Jing.. The role of Skp2/p27 axis in the occurrence and development of colorectal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1054-1058.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!